A Simple Supplement That Reduces a Dangerous Biomarker
In 2004, a team of University of California researchers led by Dr. Gladys Block, professor of epidemiology and public health nutrition at UC Berkeley, demonstrated for the first time that vitamin C supplements can lower C-reactive protein levels in the blood. The finding, published in the Journal of the American College of Nutrition (April 2004), was straightforward and powerful: 500 milligrams of vitamin C per day produced a 24% reduction in plasma CRP levels in just two months.
C-reactive protein is one of the most important markers of chronic inflammation — the same silent, persistent inflammatory state that drives heart disease, type 2 diabetes, and Alzheimer’s disease. A 24% reduction in this marker from an inexpensive, widely available supplement was a significant finding.
Dr. Block’s comment at the time was prescient: “C-reactive protein is a marker of inflammation, and there is a growing body of evidence that chronic inflammation is linked to an increased risk of heart disease, diabetes and even Alzheimer’s disease. If our finding of vitamin C’s ability to lower CRP is confirmed through other trials, vitamin C could become an important public health intervention.”
Twenty-one years later, those confirmatory trials have been conducted, the CRP-disease connections have been firmly established, and the case for vitamin C as a daily anti-inflammatory intervention is stronger than ever.
What Is C-Reactive Protein and Why Does It Matter?
C-reactive protein is a substance produced by the liver in response to inflammation anywhere in the body. When tissues are inflamed — whether from infection, injury, toxic exposure, or chronic disease processes — the liver releases CRP into the bloodstream. Measuring CRP levels provides a window into the body’s overall inflammatory status.
The Two Types of CRP Testing
Standard CRP tests detect elevated levels associated with acute conditions like infections or autoimmune flare-ups. High-sensitivity CRP (hs-CRP) tests can detect the much lower levels of chronic, low-grade inflammation that are associated with long-term disease risk. This is the test most relevant to cardiovascular and brain health assessment.
What the Numbers Mean
For hs-CRP, levels below 1.0 mg/L indicate low cardiovascular and inflammatory risk. Levels between 1.0 and 3.0 mg/L indicate moderate risk. Levels above 3.0 mg/L indicate high risk and suggest significant chronic inflammation. Levels consistently above 10 mg/L typically indicate an active infection or acute inflammatory condition that needs direct medical attention.
Why Chronic Low-Grade Inflammation Is Dangerous
The Block study specifically noted that chronic inflammation accompanied by elevated CRP has been found in smokers, type 2 diabetics, and obese and overweight individuals. But the implications extend far beyond these groups.
Elevated CRP is now recognized as an independent risk factor for cardiovascular disease — often a stronger predictor than LDL cholesterol. It is associated with increased risk of type 2 diabetes, independent of obesity. It is linked to multiple types of cancer. And critically for the Frequency Research Foundation’s work, elevated CRP is associated with increased risk of Alzheimer’s disease and accelerated cognitive decline.
The Block Study: What the Research Found
The randomized controlled trial that prompted this article was well-designed and produced clear results.
Study Design
One hundred sixty healthy adults who smoked or were exposed to secondhand smoke were randomly assigned to one of three groups: 515 milligrams of vitamin C daily, an antioxidant mixture containing vitamin C, alpha-tocopherol, gamma-tocopherol, tocotrienols, and alpha-lipoic acid, or a placebo. The treatment period was two months, with blood samples analyzed for CRP before and after.
The Results
The findings were unambiguous. The placebo group showed a small increase in CRP levels over the two-month period — their inflammation was getting slightly worse without intervention. The antioxidant mixture group showed a small reduction in CRP — a modest benefit. The vitamin C group showed a 24% reduction in plasma CRP levels — a substantial and clinically meaningful decrease from a single, inexpensive supplement.
Why Vitamin C Alone Outperformed the Antioxidant Mix
An interesting aspect of the study was that vitamin C alone produced a larger CRP reduction than the combination antioxidant formula. This may seem counterintuitive — shouldn’t more antioxidants produce more benefit? The likely explanation is that vitamin C’s effect on CRP operates through specific anti-inflammatory pathways beyond simple antioxidant activity, and that the dosing of vitamin C in the combination formula was diluted by the other components.
This finding reinforced vitamin C’s unique role as not just an antioxidant but a direct anti-inflammatory agent with measurable impact on a key disease biomarker.
CRP and Alzheimer’s Disease
The connection between elevated CRP and Alzheimer’s disease is directly relevant to everything we work on at the Frequency Research Foundation.
The Evidence Linking CRP to Cognitive Decline
Multiple large studies have now documented that people with chronically elevated CRP levels have significantly higher rates of cognitive decline and Alzheimer’s disease. The Honolulu-Asia Aging Study found that men with CRP levels in the highest quartile (25 years before dementia assessment) had a three-fold increased risk of developing Alzheimer’s and other dementias. The Rotterdam Study found similar associations between midlife inflammatory markers and later dementia risk.
The mechanism is well understood. Chronically elevated CRP both reflects and contributes to neuroinflammation — the same persistent brain inflammation that activates microglia, damages neurons, impairs amyloid clearance, and drives Alzheimer’s progression. CRP itself can cross the blood-brain barrier and directly promote inflammatory signaling in brain tissue.
Lowering CRP as an Alzheimer’s Prevention Strategy
If elevated CRP reflects the chronic inflammation that drives Alzheimer’s, then lowering CRP through simple interventions like vitamin C supplementation is a rational prevention strategy. It does not address the root cause of the inflammation — that requires identifying and eliminating the specific triggers (infections, toxins, metabolic dysfunction) — but it reduces the inflammatory burden while those root causes are being addressed.
This is where vitamin C supplementation and frequency therapy work together. Vitamin C lowers the background level of systemic inflammation measurable through CRP. Frequency therapy targets the specific infections, toxins, and disruptions that are generating the inflammation in the first place. The combination addresses inflammation from both directions simultaneously.
Our article Eliminating Inflammation Is a Top Priority for Disease Prevention provides the comprehensive framework for understanding why inflammation management is the foundational strategy for preventing chronic disease, including Alzheimer’s.
2025 Update: Two Decades of Confirmation
Since Dr. Block’s study was published in 2004, the evidence for vitamin C’s anti-inflammatory effects has been replicated and expanded significantly.
Meta-Analyses Confirm the Finding
Multiple systematic reviews and meta-analyses have now confirmed that vitamin C supplementation reduces CRP levels. A comprehensive meta-analysis published in Nutrients pooled data from numerous randomized controlled trials and confirmed a statistically significant reduction in CRP with vitamin C supplementation, with the greatest effects observed in people with the highest baseline CRP levels — exactly the population at greatest disease risk.
The NIH Follow-Up
Dr. Block was awarded a National Institutes of Health grant to conduct a larger confirmatory trial. Her subsequent research continued to support vitamin C’s role as an accessible anti-inflammatory intervention, and her broader body of work on dietary inadequacy and inflammation has influenced public health nutrition recommendations.
CRP Testing Has Gone Mainstream
In 2004, hs-CRP testing was relatively uncommon outside of research settings. Today, it is a standard component of cardiovascular risk assessment and is increasingly used in integrative and functional medicine to monitor overall inflammatory status. This means that vitamin C’s CRP-lowering effect can be tracked and verified by any individual through routine blood testing — making it one of the most measurable nutritional interventions available.
Vitamin C and Immune Function During COVID
The COVID-19 pandemic brought renewed attention to vitamin C’s role in immune function and inflammation management. Multiple studies during the pandemic examined vitamin C’s effects on inflammatory markers in COVID patients, and several found meaningful reductions in CRP and other inflammatory markers with high-dose vitamin C protocols. While the COVID application was acute rather than chronic, it reinforced vitamin C’s anti-inflammatory capabilities and brought mainstream attention to a nutrient that the Frequency Research Foundation had been recommending for over two decades.
Practical Guidance: Vitamin C for Inflammation Management
Based on the research, here is what the evidence supports for using vitamin C to lower CRP and manage chronic inflammation.
Dosage
The Block study used 515 mg daily and achieved a 24% CRP reduction. Dr. Block herself recommended 500 mg daily as a safe and effective dose. Some practitioners recommend higher doses (1,000-2,000 mg daily) for individuals with significantly elevated CRP. Doses should be divided throughout the day (e.g., 250 mg twice daily or 500 mg twice daily) for better absorption and sustained blood levels. Vitamin C is water-soluble, so excess is excreted rather than accumulated — making toxicity risk very low.
Forms
Ascorbic acid is the most studied and cost-effective form. Buffered vitamin C (calcium ascorbate or sodium ascorbate) is gentler on the stomach for people who experience digestive discomfort with ascorbic acid. Liposomal vitamin C offers enhanced absorption and may be preferable for higher-dose protocols. Whole-food vitamin C complexes include bioflavonoids that may enhance absorption and activity.
Monitoring Your Results
One of the most empowering aspects of this strategy is that it is measurable. Request an hs-CRP blood test before starting supplementation to establish your baseline. Retest after 8-12 weeks of consistent supplementation. A meaningful reduction confirms that the strategy is working for you. Continue monitoring hs-CRP periodically as part of routine health assessment.
Dietary Sources
While supplementation provides a reliable, measured dose, dietary vitamin C remains important. The richest food sources include bell peppers (especially red), citrus fruits, kiwifruit, strawberries, broccoli, Brussels sprouts, and tomatoes. A diet rich in these foods provides vitamin C alongside hundreds of other anti-inflammatory compounds.
How Vitamin C Fits Into the Bigger Picture
Vitamin C’s CRP-lowering effect is one strategy within a comprehensive anti-inflammatory approach. It works alongside other evidence-based nutritional interventions that our Alzheimer’s content cluster covers in detail.
Omega-3 fatty acids from fish oil produce specialized pro-resolving mediators that actively shut down inflammatory processes. Our articles on fish consumption reducing Alzheimer’s risk and fish oil preventing Alzheimer’s cover this evidence. Oleocanthal in extra-virgin olive oil inhibits the same COX enzymes as ibuprofen, providing daily anti-inflammatory action through food. Take Olive Oil Instead of Ibuprofen covers the research. Resveratrol in red wine suppresses NF-κB, a master regulator of inflammatory gene expression. Red Wine Cuts Alzheimer’s Risk by 45% covers this evidence. B vitamin supplementation lowers homocysteine, another inflammatory and neurotoxic factor. Homocysteine, heart disease, and Alzheimer disease covers this modifiable biomarker.
Layered together, these nutritional strategies create a comprehensive anti-inflammatory foundation. Frequency therapy then addresses the root causes of inflammation — chronic infections, environmental toxins, and disrupted electromagnetic signaling — that nutrition alone cannot reach.
For the complete picture, read our complete guide to Alzheimer’s disease and frequency therapy.
Want a comprehensive anti-inflammatory strategy combining targeted nutrition with frequency therapy? Dr. Jeff Sutherland offers personalized paid consultations to assess your inflammatory markers and develop a multi-layered protocol tailored to your specific triggers. Book Your Consultation
Frequently Asked Questions
Take the Next Step
Lowering CRP through vitamin C supplementation is one of the simplest, most measurable, and most affordable steps you can take for long-term health. Combined with other anti-inflammatory nutritional strategies and frequency therapy to address the root causes of chronic inflammation, the potential for disease prevention is substantial.
A consultation with Dr. Jeff Sutherland can help you understand your full inflammatory profile and develop a personalized protocol that combines targeted nutrition with frequency-based approaches.
Book Your Consultation with Dr. Jeff Sutherland
This article is part of our comprehensive Alzheimer’s resource library. Chronic inflammation, measured by CRP, is a primary driver of Alzheimer’s progression. Read our complete guide to Alzheimer’s disease and frequency therapy for the full scope of anti-inflammatory, nutritional, and frequency-based strategies for brain health.
© Frequency Research Foundation. This content is for educational and informational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals regarding medical conditions and supplementation.
